Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 253 to 257 of 257 entries
Sorted by: Best Match Show Resources per page
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.

JAMA cardiology

Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ.
PMID: 34374713
JAMA Cardiol. 2021 Dec 01;6(12):1451-1460. doi: 10.1001/jamacardio.2021.3444.

IMPORTANCE: The COVID-19 pandemic saw one of the fastest developments of vaccines in an effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine platforms currently in use, messenger RNA (mRNA) and adenovirus vector, were developed on...

Cite
Rizk JG, Gupta A, Sardar P, et al. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021;6(12):1451-1460doi: 10.1001/jamacardio.2021.3444.
Rizk, J. G., Gupta, A., Sardar, P., Henry, B. M., Lewin, J. C., Lippi, G., & Lavie, C. J. (2021). Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA cardiology, 6(12), 1451-1460. https://doi.org/10.1001/jamacardio.2021.3444
Rizk, John G, et al. "Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review." JAMA cardiology vol. 6,12 (2021): 1451-1460. doi: https://doi.org/10.1001/jamacardio.2021.3444
Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 Dec 01;6(12):1451-1460. doi: 10.1001/jamacardio.2021.3444. PMID: 34374713.
Copy Download .nbib Format: NLM
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.

JAMA cardiology

Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ.
PMID: 34374713
JAMA Cardiol. 2021 Dec 01;6(12):1451-1460. doi: 10.1001/jamacardio.2021.3444.

IMPORTANCE: The COVID-19 pandemic saw one of the fastest developments of vaccines in an effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine platforms currently in use, messenger RNA (mRNA) and adenovirus vector, were developed on...

Cite
Rizk JG, Gupta A, Sardar P, et al. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021;6(12):1451-1460doi: 10.1001/jamacardio.2021.3444.
Rizk, J. G., Gupta, A., Sardar, P., Henry, B. M., Lewin, J. C., Lippi, G., & Lavie, C. J. (2021). Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA cardiology, 6(12), 1451-1460. https://doi.org/10.1001/jamacardio.2021.3444
Rizk, John G, et al. "Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review." JAMA cardiology vol. 6,12 (2021): 1451-1460. doi: https://doi.org/10.1001/jamacardio.2021.3444
Rizk JG, Gupta A, Sardar P, Henry BM, Lewin JC, Lippi G, Lavie CJ. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 Dec 01;6(12):1451-1460. doi: 10.1001/jamacardio.2021.3444. PMID: 34374713.
Copy Download .nbib Format: NLM
Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).

Journal of leukocyte biology

Kashir J, Ambia AR, Shafqat A, Sajid MR, AlKattan K, Yaqinuddin A.
PMID: 34467562
J Leukoc Biol. 2021 Sep 01; doi: 10.1002/JLB.5COVR0621-320RR. Epub 2021 Sep 01.

Following on from the devastating spread of COVID-19, a major global priority has been the production, procurement, and distribution of effective vaccines to ensure that the global pandemic reaches an end. However, concerns were raised about worrying side effects,...

Cite
Kashir J, Ambia AR, Shafqat A, et al. Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT). J Leukoc Biol. 2021;doi: 10.1002/JLB.5COVR0621-320RR.
Kashir, J., Ambia, A. R., Shafqat, A., Sajid, M. R., AlKattan, K., & Yaqinuddin, A. (2021). Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT). Journal of leukocyte biology, . https://doi.org/10.1002/JLB.5COVR0621-320RR
Kashir, Junaid, et al. "Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT)." Journal of leukocyte biology vol. (2021). doi: https://doi.org/10.1002/JLB.5COVR0621-320RR
Kashir J, Ambia AR, Shafqat A, Sajid MR, AlKattan K, Yaqinuddin A. Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT). J Leukoc Biol. 2021 Sep 01; doi: 10.1002/JLB.5COVR0621-320RR. Epub 2021 Sep 01. PMID: 34467562.
Copy Download .nbib Format: NLM
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.

Thrombosis research

Liu Y, Shao Z, Wang H.
PMID: 34894531
Thromb Res. 2021 Dec 06;209:75-79. doi: 10.1016/j.thromres.2021.12.002. Epub 2021 Dec 06.

SARS-CoV-2 vaccines have been carefully developed and significantly alleviate the global pandemic. However, a rare but severe complication after vaccination of adenoviral vector vaccines has attracted worldwide attention. It is characterized by thrombosis at unusual sites (often cerebral or...

Cite
Liu Y, Shao Z, Wang H. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Thromb Res. 2021;209:75-79doi: 10.1016/j.thromres.2021.12.002.
Liu, Y., Shao, Z., & Wang, H. (2021). SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Thrombosis research, 20975-79. https://doi.org/10.1016/j.thromres.2021.12.002
Liu, Yumei, et al. "SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia." Thrombosis research vol. 209 (2021): 75-79. doi: https://doi.org/10.1016/j.thromres.2021.12.002
Liu Y, Shao Z, Wang H. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Thromb Res. 2021 Dec 06;209:75-79. doi: 10.1016/j.thromres.2021.12.002. Epub 2021 Dec 06. PMID: 34894531; PMCID: PMC8647389.
Copy Download .nbib Format: NLM
Pulsed Radiofrequency Neuromodulation Contributes to Activation of Platelet-Rich Plasma in In Vitro Conditions.

Neuromodulation : journal of the International Neuromodulation Society

Michno A, Kirkor Z, Gojtowska E, Suchorzewski M, Śmietańska I, Baścik B.
PMID: 32027438
Neuromodulation. 2021 Dec;24(8):1451-1457. doi: 10.1111/ner.13105. Epub 2020 Feb 06.

OBJECTIVES: Recent years have brought new developments in interventional chronic pain management, namely regenerative orthopedics utilizing platelet-rich plasma (PRP) as well as further evolution of pulsed radiofrequency neuromodulation (PRF). Both methods have been used separately. Here, we investigated whether...

Cite
Michno A, Kirkor Z, Gojtowska E, et al. Pulsed Radiofrequency Neuromodulation Contributes to Activation of Platelet-Rich Plasma in In Vitro Conditions. Neuromodulation. 2020;24(8):1451-1457doi: 10.1111/ner.13105.
Michno, A., Kirkor, Z., Gojtowska, E., Suchorzewski, M., Śmietańska, I., & Baścik, B. (2021). Pulsed Radiofrequency Neuromodulation Contributes to Activation of Platelet-Rich Plasma in In Vitro Conditions. Neuromodulation : journal of the International Neuromodulation Society, 24(8), 1451-1457. https://doi.org/10.1111/ner.13105
Michno, Anna, et al. "Pulsed Radiofrequency Neuromodulation Contributes to Activation of Platelet-Rich Plasma in In Vitro Conditions." Neuromodulation : journal of the International Neuromodulation Society vol. 24,8 (2021): 1451-1457. doi: https://doi.org/10.1111/ner.13105
Michno A, Kirkor Z, Gojtowska E, Suchorzewski M, Śmietańska I, Baścik B. Pulsed Radiofrequency Neuromodulation Contributes to Activation of Platelet-Rich Plasma in In Vitro Conditions. Neuromodulation. 2021 Dec;24(8):1451-1457. doi: 10.1111/ner.13105. Epub 2020 Feb 06. PMID: 32027438.
Copy Download .nbib Format: NLM
Showing 253 to 257 of 257 entries